Company Description
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.
The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM).
It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures.
The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market.
It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019.
Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
| Country | United States |
| Founded | 1982 |
| IPO Date | Jan 1, 1987 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 220 |
| CEO | Charles Goodwin |
Contact Details
Address: 5115 Ulmerton Road Clearwater, Florida 33760-4004 United States | |
| Phone | 727 384 2323 |
| Website | apyxmedical.com |
Stock Details
| Ticker Symbol | APYX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000719135 |
| CUSIP Number | 03837C106 |
| ISIN Number | US03837C1062 |
| Employer ID | 11-2644611 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Charles D. Goodwin II | President, Chief Executive Officer and Director |
| Stavros George Vizirgianakis B.Com. | Executive Chairman |
| Matthew C. Hill CPA | Chief Financial Officer, Treasurer and Secretary |
| Shawn D. Roman | Chief Operating Officer |
| Moshe Citronowicz | Senior Vice President |
| Dolores Catania | Chief of Confidence |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 19, 2025 | 8-K | Current Report |
| Nov 18, 2025 | 424B5 | Filing |
| Nov 17, 2025 | 424B5 | Filing |
| Nov 6, 2025 | 10-Q | Quarterly Report |
| Nov 6, 2025 | 8-K | Current Report |
| Aug 13, 2025 | 8-K | Current Report |
| Aug 7, 2025 | 10-Q | Quarterly Report |
| Aug 7, 2025 | 8-K | Current Report |
| Jun 25, 2025 | DEF 14A | Other definitive proxy statements |
| Jun 13, 2025 | PRE 14A | Other preliminary proxy statements |